2m 2m 2m 2m 2m 2m 2m
Amgen (AMGN)
NASDAQ
$387.16+$1.99 (+0.52%)
Price as of Jul 31, 2026 7:50 PM EDT- $209.2BMarket Cap
- 33.64%1-Year Change
- Drug Manufacturers - GeneralIndustry
Amgen (AMGN)
$387.16+$1.99 (+0.52%)
Earnings Score
Valuation | AMGN | vs History | vs S&P 500 |
|---|---|---|---|
Profitability | 1 | ||
Growth | -0 | ||
Low Earnings Volatility | 0 |
Momentum Score
Valuation | AMGN | vs History | vs S&P 500 |
|---|---|---|---|
3-Month Momentum | 7.21% | ||
12-Month Momentum | 26.12% | ||
3-Month Risk Adjusted Momentum | 65.35% | ||
12-Month Risk Adjusted Momentum | 100.21% |
True Yield
Valuation | AMGN | vs History | vs S&P 500 |
|---|---|---|---|
Dividend Yield | 2.62% | ||
Net Buyback Yield | N/A | ||
Net Debt Paydown Yield | -1.62% |
Financial Health Score
Valuation | AMGN | vs History | vs S&P 500 |
|---|---|---|---|
Ohlson's O-Score | 7 |